PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
4 hedge funds and large institutions have $1.09K invested in PAVmed Inc. Series Z Warrant in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
42% less capital invested
Capital invested by funds: $1.87K → $1.09K (-$780)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$102 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$41 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$11 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $837 | +$102 | +11,213 | +8% |
|
|
2
Citadel Advisors
Miami,
Florida
| $234 | -$11 | -1,171 | -3% |
|
|
3
UBS Group
Zurich,
Switzerland
| $20 | -$41 | -4,503 | -58% |
|
PAVMZ Hedge Fund Activity: Q1 2025 in Review
4 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q1 2025, worth a combined $1.09K — down 42% from $1.87K a quarter earlier.
Fund positioning in PAVMZ was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $102. The largest seller was UBS Group, cutting an estimated $41.
- 4 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $1.09K of PAVmed Inc. Series Z Warrant stock for Q1 2025, down 42% quarter-over-quarter.
- 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q1 2025 and 0 closed out.
- The largest PAVmed Inc. Series Z Warrant buyer in Q1 2025 was Susquehanna International Group, an estimated $102 added.
- The largest PAVmed Inc. Series Z Warrant seller in Q1 2025 was UBS Group, an estimated $41 sold.
Based on aggregated 13F filings for Q1 2025.